case_id,count,combos,patient_info,document_name,Q3_baseline,Q3_rag,Q3_gt
Case10363,4,"['top1_10retrieve', 'top1_30retrieve', 'top3_10retrieve', 'top3_30retrieve']",The patient is a 7-year-old child with a congenital anomaly present since birth who was referred by the general practitioner for whole genome sequencing (WGS) after fluorescence in situ hybridization (FISH) testing was nondiagnostic. The family history is notable for a maternal aunt with pancreatic cancer and the family has coverage through UHC. The patient has been seen multiple times by a genetic counselor for pre-test counseling and plans for post-test follow-up are in place. WGS is being pursued to provide a comprehensive genomic evaluation given the longstanding congenital findings and prior nondiagnostic targeted testing.,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case7376,4,"['top1_10retrieve', 'top1_30retrieve', 'top3_10retrieve', 'top3_30retrieve']","The patient is a 73-year-old referred by a neurologist for evaluation of a major abnormality involving at least one organ system that remains unexplained, and whole exome sequencing (WES) has been ordered for diagnostic clarification. Prior fluorescent in situ hybridization testing was nondiagnostic. The patient reports that a sister had triple negative breast cancer, which raises concern for an underlying heritable predisposition. Pre-test counseling was completed with a genetic specialist and testing will proceed with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case2496,4,"['top1_10retrieve', 'top1_30retrieve', 'top3_10retrieve', 'top3_30retrieve']","A prenatal evaluation at 32 weeks' gestation has been requested by a neonatologist for whole exome sequencing (WES) with coverage through UHC because of parental consanguinity and concern for autosomal recessive conditions, there is a reported family history of sudden unexplained death in a sibling before age 35, prior fluorescence in situ hybridization testing was nondiagnostic, and no genetic counseling has been completed, so WES is being pursued to assess risk for potential postnatal outcomes based on fetal imaging and to guide perinatal planning.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case18821,4,"['top1_10retrieve', 'top1_30retrieve', 'top3_10retrieve', 'top3_30retrieve']","The obstetrician requests fetal whole exome sequencing (WES) at 22 weeks' gestation after prenatal imaging identified findings concerning for multiple congenital anomalies affecting different organ systems, and the test is intended to evaluate a possible genetic etiology to inform perinatal counseling and management. Family history is notable for a maternal aunt reported to have dysmorphic features. There is no prior genetic testing and no documentation of pre-test genetic counseling, and the patient has coverage through the Blue Cross Blue Shield Federal Employee Program (BCBS_FEP).",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case17822,3,"['top1_10retrieve', 'top1_30retrieve', 'top3_10retrieve']","The patient is a 13-year-old referred to medical genetics for evaluation of multiple congenital anomalies affecting different organ systems, and whole genome sequencing (WGS) has been ordered as the next-tier diagnostic test after a nondiagnostic chromosomal microarray (CMA). The family history is notable for a sibling with short stature, genetic counseling was declined prior to testing, and the order was placed by a medical geneticist with coverage through UHC, with plans to review results and coordinate further evaluation and management as indicated.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case5380,3,"['top1_10retrieve', 'top3_10retrieve', 'top3_30retrieve']","An 8-week-old infant is referred by neurology for evaluation of high-risk brief resolved unexplained events (BRUE) with recurrent witnessed seizure-like episodes, and whole genome sequencing (WGS) is requested to assess for an underlying genetic cause; prior chromosomal microarray (CMA) testing was nondiagnostic, and there is a maternal history of short stature as a growth abnormality, the family declined pre-test genetic counseling, and testing will be pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case6747,3,"['top1_10retrieve', 'top1_30retrieve', 'top3_30retrieve']","A 12-year-old child with multiple congenital anomalies is undergoing whole genome sequencing (WGS) ordered by the medical geneticist to evaluate a suspected genetic etiology. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic. The family reports a sibling with developmental delay, pre-test counseling has been completed and post-test counseling is planned, and the patient has coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case5885,3,"['top1_10retrieve', 'top1_30retrieve', 'top3_30retrieve']","An 11-year-old patient was referred by neurology for evaluation of a major abnormality affecting at least one organ system and whole genome sequencing (WGS) is requested to investigate an underlying genetic cause, Fragile X testing was previously performed and was nondiagnostic, and there is a family history of long QT syndrome in the mother; pre-test counseling was discussed with a genetic specialist and plans for post-test follow-up are in place with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case2162,3,"['top1_10retrieve', 'top1_30retrieve', 'top3_30retrieve']","An infant aged 7 weeks was referred by a general practitioner for whole genome sequencing (WGS) to evaluate multiple congenital anomalies affecting multiple organ systems identified at birth; prior Fragile X testing was nondiagnostic, the family history is notable for an older sibling with autism spectrum disorder, pre-test genetic counseling has been completed with plans for post-test follow-up, and the family has coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case11514,3,"['top1_10retrieve', 'top1_30retrieve', 'top3_30retrieve']","The 10-year-old patient is being evaluated for conjugated hyperbilirubinemia not attributable to total parenteral nutrition and whole exome sequencing (WES) has been requested to investigate a potential genetic cause of cholestatic liver disease; a chromosomal microarray (CMA) was previously performed and was nondiagnostic. There is a family history of an inborn error of metabolism in a cousin, which raises concern for an inherited metabolic disorder contributing to the hepatic phenotype. The test was ordered by the patient's oncologist, coverage is through UHC, and there is no documentation of pre-test genetic counseling.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case13983,3,"['top1_10retrieve', 'top1_30retrieve', 'top3_10retrieve']","The patient is a 7-week-old infant being evaluated for a high-risk brief resolved unexplained event (BRUE) with a significantly abnormal electrocardiogram (ECG) that raises concern for an underlying channelopathy, arrhythmia, cardiomyopathy, myocarditis, or structural heart disease, and whole genome sequencing (WGS) is being pursued at the request of the ordering gynecologist given the concerning cardiac findings and family history. Prior fluorescent in situ hybridization testing was nondiagnostic. The maternal uncle has a history of unexplained developmental regression reported as unrelated to autism or epilepsy and this family history prompted consideration of an inherited etiology. Pre-test counseling was completed with a genetic counselor and plans are in place for post-test follow-up, and testing will be billed through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,Not Specified,Yes
Case13675,3,"['top1_10retrieve', 'top1_30retrieve', 'top3_30retrieve']","The patient is an 8-week-old infant referred by a neonatologist for evaluation of significant congenital hearing and/or visual impairment identified in early infancy, and whole genome sequencing (WGS) is being pursued for diagnostic clarification; prior fluorescence in situ hybridization testing was nondiagnostic. The family history is notable for a father with long QT syndrome, which will be considered in interpretation of any cardiac-associated findings. There is no documentation of pre-test genetic counseling and testing is being requested with coverage through UHC with planned post-test follow-up by the neonatal team.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case5605,2,"['top1_10retrieve', 'top1_30retrieve']","The patient is an 11-year-old being evaluated for a major congenital cardiac anomaly and was referred by an obstetrician for whole genome sequencing (WGS) to assess for an underlying genetic cause. A prior chromosomal microarray (CMA) was nondiagnostic, pre-test counseling was completed with a genetic specialist, and insurance coverage is through BCBS_FEP. Family history is notable for a maternal aunt with pancreatic cancer.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case4512,2,"['top1_10retrieve', 'top1_30retrieve']","The patient is a 21-year-old referred by the primary care physician for evaluation of a major congenital cardiac anomaly present since birth, and whole genome sequencing (WGS) is being pursued to identify a potential genetic etiology; there is a family history of a sibling who experienced a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor, and irregular breathing which raised concern for a heritable predisposition, and no prior genetic testing has been performed, pre-test counseling was completed with a genetic counselor and a post-test visit is planned with testing submitted with coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case4067,2,"['top1_10retrieve', 'top1_30retrieve']","The 5-year-old was referred by a developmental pediatrician for evaluation of significant hypotonia and whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology; prior chromosomal karyotype testing was nondiagnostic, and there is a family history of sudden unexplained death in a paternal uncle before age 35 that raises concern for a heritable disorder, with the family reporting coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case6451,2,"['top1_10retrieve', 'top1_30retrieve']","The 7-week-old infant was evaluated by a developmental pediatrician for significant hypotonia and whole genome sequencing (WGS) is being pursued to identify a potential genetic cause. The family reports that the mother has a history of a persistent, severe immunologic or hematologic disorder. A prior karyotype was nondiagnostic. Pre-test counseling has been completed and post-test follow-up with genetics is planned, and testing is being obtained with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case13613,2,"['top1_30retrieve', 'top3_30retrieve']","At 22 weeks' gestation fetal imaging identified multiple structural anomalies and the pregnancy was referred by neurology for evaluation with whole exome sequencing (WES) to assess potential genetic etiologies that could inform postnatal management and counseling. Fragile X testing was previously performed and was nondiagnostic. There is a family history of dysmorphic features in a maternal aunt, and pre-test discussion occurred with a genetic specialist and testing will be pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case1428,2,"['top1_10retrieve', 'top1_30retrieve']","The three-week-old infant is being evaluated by a medical geneticist for Hirschsprung disease and whole genome sequencing (WGS) has been ordered to assess for an underlying genetic cause given a family history of an older sibling with severe intellectual disability diagnosed by age 18. Fragile X testing was previously performed and was nondiagnostic, and there is no documented pre-test genetic counseling. Testing will be submitted through UHC for coverage.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case13406,2,"['top1_10retrieve', 'top3_10retrieve']","The infant is 6 weeks of age and is being evaluated for concern of global developmental delay, with a family history notable for a sibling who experienced a brief resolved unexplained event described as altered level of responsiveness with cyanosis, pallor, and irregular breathing; chromosomal microarray (CMA) was previously performed and was nondiagnostic. Whole genome sequencing (WGS) has been ordered by a medical geneticist to assess for an underlying genetic etiology, pre-test counseling has been completed, and the family will follow up with the genetic counselor after results, with testing submitted for coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case19162,2,"['top1_10retrieve', 'top3_30retrieve']","The infant is a neonate presenting with complex neurologic abnormalities including dystonia, ataxia, and asymmetric weakness suggestive of neonatal hemiplegia and was referred by a medical geneticist for whole genome sequencing (WGS) to evaluate for an underlying genetic or metabolic cause. Fragile X testing was previously performed and was nondiagnostic, and there is a family history of an inborn error of metabolism in a sibling. Pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, and testing will be pursued with coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case811,2,"['top1_10retrieve', 'top1_30retrieve']","The patient is a 7-week-old infant referred by the general pediatrician for evaluation of early-onset movement abnormalities characterized by dystonia, ataxia and intermittent hemiplegic episodes concerning for a neuromuscular or movement disorder, and chromosomal microarray (CMA) was previously performed and reported as nondiagnostic; given the clinical presentation and a positive family history in an older sibling with multiple congenital anomalies, whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology, pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, and testing is being ordered with coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case14371,1,['top3_10retrieve'],"An 11-year-old with complex neurodevelopmental disorder and autism spectrum disorder is being evaluated by the general pediatrician who has ordered whole exome sequencing (WES) to investigate an underlying genetic etiology; prior Fragile X testing was nondiagnostic, and there is a family history of a maternal aunt with a persistent severe immunologic disorder, which may inform interpretation of results, and the family met with a genetic counselor before testing with plans for post-test follow-up, with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case14226,1,['top1_10retrieve'],"A 55-year-old patient is being evaluated by oncology for germline BRCA1 and BRCA2 (BRCA1/2) testing because they have a personal history of a primary solid tumor other than basal or squamous cell skin cancer and risk assessment using Tyrer-Cuzick, BRCAPro, or Penn II calculators demonstrates a 2.5% or greater likelihood of a BRCA pathogenic variant; the patient has not undergone prior genetic testing and no pre-test genetic counseling was completed, and family history is notable for a mother with a persistent, severe hematologic or immunologic disorder, with testing being pursued with coverage through Cigna and results to be reviewed by the oncology team to inform management.",Cigna_MOL.TS_.238.A_BRCA_Analysis_eff01.01.2025_pub09.10.2024_1.pdf,No,Not Specified,No
Case13,1,['top1_10retrieve'],"The newborn is being evaluated by the general pediatrician for multiple congenital anomalies that do not fit a well-delineated genetic syndrome and has been referred for whole exome sequencing (WES) after karyotype testing was nondiagnostic, there is a family history of a sibling with unexplained developmental regression unrelated to autism or epilepsy, pre-test genetic counseling was completed and post-test follow-up is planned, and testing will be submitted with coverage through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case15938,1,['top3_10retrieve'],"The patient is a one-week-old infant under the care of a neonatologist being evaluated for conjugated hyperbilirubinemia not related to total parenteral nutrition and whole-genome sequencing (WGS) is being considered to identify a potential genetic cholestatic or metabolic etiology; prior karyotype testing was nondiagnostic, there is a family history of a sibling with unexplained developmental regression unrelated to autism or epilepsy, no pretest genetic counseling is documented, and the family has coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
Case7447,1,['top1_30retrieve'],"At 33 weeks' gestation, fetal imaging raises concern for an isolated severe congenital heart defect and the cardiologist has ordered whole genome sequencing (WGS) to evaluate for a possible genetic etiology and to guide postnatal management; prior fragile X testing was nondiagnostic, family history is notable for a maternal aunt with triple-negative breast cancer, there is no documentation of pre-test genetic counseling, and coverage is through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case8051,1,['top1_10retrieve'],"An infant of 5 weeks with a major congenital cardiac anomaly is being evaluated with whole exome sequencing (WES) ordered by the family medicine physician, and prior fluorescence in situ hybridization testing was nondiagnostic; the history is notable for a mother with short stature raising concern for a growth-related genetic condition, the family completed pre-test genetic counseling and will follow up after results, and testing is being pursued to clarify the etiology of the cardiac defect and potential syndromic associations with billing through BCBS_FEP.",BCBS_FEP_204102 Whole Exome and.pdf,Yes,No,Yes
Case8621,1,['top3_10retrieve'],"A 2-year-old child with a complex neurodevelopmental disorder with autism is undergoing evaluation with whole exome sequencing (WES) to seek a unifying diagnosis after prior chromosomal microarray (CMA) testing was nondiagnostic; the test was ordered by the childâ€™s oncologist and is planned with coverage through UHC, the family reports an uncle with a congenital anomaly as relevant family history, and the family has met with a genetic counselor multiple times with pre-test counseling completed and plans for post-test follow-up.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Yes,No,Yes
